| 2010 | ||
| 1. | Shimokawa N, Haglund K, Hölter SM, Grabbe C, Kirkin V, Koibuchi N, Schultz C, Rozman J, Hoeller D, Qiu CH, Londoño MB, Ikezawa J, Jedlicka P, Stein B, Schwarzacher SW, Wolfer DP, Ehrhardt N, Heuchel R, Nezis I, Brech A, Schmidt MH, Fuchs H, Gailus-Durner V, Klingenspor M, Bogler O, Wurst W, Deller T, de Angelis MH, Dikic I. CIN85 regulates dopamine receptor endocytosis and governs behaviour in mice. EMBO J. 2010, In press |
|
| 2. | Deribe YL, Pawson T, Dikic I. Post-translational modifications in signal integration. Nat Struct Mol Biol. 2010, 17(6):666-72. | |
| 3. | Dikic I, Schmidt MH. Notch: Implications of endogenous inhibitors for therapy. Bioessays. 2010, 32(6):481-7. | |
| 4. | McEwan DG, Dikic I. Not all autophagy membranes are created equal. Cell. 2010, 141(4):564-6. | |
| 5. | Haglund K, Nezis IP, Lemus D, Grabbe C, Wesche J, Liestøl K, Dikic I, Palmer R, Stenmark H. Cindr interacts with anillin to control cytokinesis in Drosophila melanogaster. Curr Biol. 2010, 20(10):944-50 | |
| 6. | Dikic I, Johansen T, Kirkin V. Selective autophagy in cancer development and therapy. Cancer Res. 2010, 70(9):3431-4. | |
| 7. | Vivanco I, Rohle D, Versele M, Iwanami A, Kuga D, Oldrini B, Tanaka K, Dang J, Kubek S, Palaskas N, Hsueh T, Evans M, Mulholland D, Wolle D, Rajasekaran S, Rajasekaran A, Liau LM, Cloughesy TF, Dikic I, Brennan C, Wu H, Mischel PS, Perera T, Mellinghoff IK. The phosphatase and tensin homolog regulates epidermal growth factor receptor (EGFR) inhibitor response by targeting EGFR for degradation. Proc Natl Acad Sci U S A. 2010, 107(14):6459-64. |
|
| 8. | Bomar MG, D'Souza S, Bienko M, Dikic I, Walker GC, Zhou P. Unconventional ubiquitin recognition by the ubiquitin-binding motif within the Y family DNA polymerases iota and Rev1. Mol Cell. 2010, 37(3):408-17. | |
| 9. | Bienko M, Green C, Sabbioneda S, Crosetto N, Matic I, Hibbert R, Begovic T, Niimi A, Mann M, Lehmann A, Dikic I. Regulation of translesion synthesis DNA polymerase h by monoubiquitination. Mol Cell 2010, 37(3):396-407. |
|
| 10. | Wild P, Dikic I. Mitochondria get a Parkin' ticket. Nat Cell Biol. 2010, 12(2):104-6. |
|
| 11. | Nagy V, Dikic I. Ubiquitin ligase complexes: from substrate selectivity to conjugational specificity. Biol Chem. 2010, 391(2-3):163-9. | |
| 11. | Novak I, Kirkin V, McEwan DG, Zhang J, Wild P, Rozenknop A, Rogov V, Löhr F, Popovic D, Occhipinti A, Reichtert A, Terzic J, Doetsch V, Paul N, Dikic I. Nix is a selective autophagy receptor for mitochondrial clearance. EMBO Reports 2010, 11(1):45-51. |
|
| 2009 | ||
| 1. | Rahighi S, Ikeda F, Kawasaki M, Akutsu M, Suzuki N, Kato R, Kensche T, Uejima T, Bloor S, Komander D, Randow F, Wakatsuki S and Dikic I. Specific recognition of linear ubiquitin chains by NEMO is important for NF-κB activation. Cell 2009, 136(6):1098-109. |
|
| 2. | Hoeller D, Dikic I. Targeting the ubiquitin system in cancer therapy. Nature 2009, 458(7237):438-44. |
|
| 3. | Dikic I, Wakatsuki S, Walters KJ. Ubiquitin-binding domains - from structures to functions. Nat Rev Mol Cell Biol 2009, 10(10):659-71. |
|
| 4. | Kirkin V, McEwan DG, Novak I, Dikic I. A Role for Ubiquitin in Selective Autophagy. Mol Cell 2009, 15;34(3):259-69. |
|
| 5. | Schmidt MH, Bicker F, Nikolic I, Meister J, Babuke T, Picuric S, Müller-Esterl W, Plate KH, Dikic I. Epidermal growth factor-like domain 7 (EGFL7) modulates Notch signalling and affects neural stem cell renewal. Nat Cell Biol 2009, 11(7):873-80. |
|
| 6. | Dikic I. Journal club. A new ubiquitin chain, a new signal. Nat Rev Mol Cell Biol 2009, 10(5):306. |
|
| 7. | Dikic I. Doetsch V. Ubiquitin linkages make a difference. Nat Struct Mol Biol 2009, 16:1209.-1210. |
|
| 8. | Kirkin V, Lamark T, Sou Y, Bjørkøy G, Nunn J, Bruun JA, Shvets E, McEwan DG, Clausen TH, Wild P, Bilusic I, Theurillat JP, Øvervatn A, Ishii T, Elazar Z, Komatsu M, Dikic I, Johansen T. A role for NBR1 is autophagosomal degradation of ubiquitinated substrates, Mol Cell 2009, 33(4):505-16. |
|
| 9. | Sabbioneda S, Green CM, Bienko M, Kannouche P, Dikic I, Lehmann AR. Ubiquitin-binding motif of human DNA polymerase eta is required for correct localization. Proc Natl Acad Sci USA 2009, 106(8):E20 |
|
| 10. | Grabbe C, Dikic I. Functional Roles of Ubiquitin-Like Domain (ULD) and Ubiquitin-Binding Domain (UBD) Containing Proteins. Chem Rev 2009, 109(4):1481-94. |
|
| 11. | Lappe-Siefke C, Loebrich S, Hevers W, Waidmann OB, Schweizer M, Fehr S, Fritschy JM, Dikic I, Eilers J, Wilson SM, Kneussel M. The ataxia (axJ) mutation causes abnormal GABAA receptor turnover in mice. PLoS Genet 2009, 5(9):e1000631. |
|
| 12. | Lamark T, Kirkin V, Dikic I, Johansen T. NBR1 and p62 as cargo receptors for selective autophagy of ubiquitinated targets. Cell Cycle 2009, Jul 30;8(13). |
|
| 13. | Kirkin V, Lamark T, Johansen T, Dikic I. NBR1 cooperates with p62 in selective autophagy of ubiquitinated targets. Autophagy 2009, 30;5(5). |
|
| 14. | Scharner D, Rössig L, Carmona G, Chavakis E, Urbich C, Fischer A, Kang TB, Wallach D, Chiang YJ, Deribe YL, Dikic I, Zeiher AM, Dimmeler S. Caspase-8 Is Involved in Neovascularization-Promoting Progenitor Cell Functions. Arterioscler Thromb Vasc Biol 2009, 571-8. |
|
| 15. | Rajalingam K and Dikic I. Inhibitors of apoptosis catch ubiquitin, Biochem J 2009, 417:e1-3. |
|
| 2008 | ||
| 1. | Grabbe C, Dikic I. Going global on ubiquitin. Science 2008, 322(5903):872-3. |
|
| 2. | Husnjak K, Elsasser S, Zhang N, Chen X, Randles L, Shi Y, Hofmann K, Walters K, Finley D, Dikic I. Proteasome subunit Rpn13 is a novel ubiquitin receptor. Nature 2008, 453:481-488. |
|
| 3. | Schreiner P, Chen X, Husnjak K, Randles L, Zhang N, Elsasser S, Finley D, Dikic I, Walters K, Groll M. Ubiquitin docking at the proteasome via a novel PH domain interaction. Nature 2008, 453:548-552. |
|
| 4. | Zagrovic B and Dikic I. Childhood of a Phoenix - modern biology in eastern and south-eastern Europe. Nature Rev Mol Cell Biol 2008, 9:333-336. |
|
| 5. | Ikeda F, Dikic I. Atypical ubiquitin chains: new molecular signals. 'Protein Modifications: Beyond the Usual Suspects' review series. EMBO Rep 2008, 9:536-42. |
|
| 6. | Schmidt-Glenewinkel H. Vacheva I, Hoeller D, Dikic I, Eils R. An ultrasensitive sorting mechanism for EGF receptor endocytosis. BMC Syst Biol 2008, 7;2:3 |
|
| 7. | Crosetto N, Bienko M, Hibbert RG, Perica T, Ambrogio C, Kensche T, Hofmann K, Sixma TK and Dikic I. Human WRNIP1 is localized in replication factories in a UBZ-dependent manner. J Biol Chem 2008, 283(50):35173-85. |
|
| 8. | Nonis D, Schmidt MH, van de Loo S, Eich F, Dikic I, Nowock J, Auburg G. Ataxin-2 associates with the endocytosis complex and affects EGF receptor trafficking. Cell Signal 2008, 20:1725-1739. |
|
| 9. | Marafioti T, Paterson JC, Ballabio E, Reichard KK, Tedoldi S, Hollowood K, Dictor M, Hansmann ML, Pileri SA, Dyer MJ, Sozzani S, Dikic I, Shaw AS, Petrella T, Stein H, Isaacson PG, Facchetti F, Mason DY. Novel markers of normal and neoplastic human plasmacytoid dendritic cells. Blood 2008, 111:3778-3792. |
|
| 10. | Wagner S, Carpentier I, Rogov V, Kreike M, Ikeda F, Löhr F, Wu CJ, Ashwell JD, Dötsch V, Dikic I, Beyaert R. Ubiquitin binding mediates the NF-B inhibitory potential of ABIN proteins. Oncogene 2008, 27:3739-45. |
|
| 11. | Guo C, Tang TS, Bienko M, Dikic I, Friedberg EC. Requirements for the Interaction of Mouse Pol with Ubiquitin and Its Biological Significance. J Biol Chem 2008, 283:4658-64. |
|
| 12. | Iha H, Peloponese JM, Verstrepen L, Zapart G, Ikeda F, Smith CD, Starost MF, Yedavalli V, Heyninck K, Dikic I, Beyaert R, Jeang KT. Inflammatory cardiac valvulitis in TAX1BP1-deficient mice through selective NF-B activation. EMBO J 2008, 27:629-41. |
|
| 13. | Bloor S, Ryzhakov G, Wagner S, Butlerý PJG, Smith DL, Dikic I, Randow F. Signal processing by its coil zipper domain activates IKK. Proc Nat Acad Sci USA 2008, 105:1279-84. |
|
| 2007 | ||
| 1. | Hoeller D, Hecker CM, Wagner S, Rogov V, Dötsch V, Dikic I. E3-independent monoubiquitination of ubiquitin-binding proteins. Mol Cell 2007, 26:891-8. |
|
| 2. | Ikeda F, Hecker CM, Rozenknop A, Nordmeier RD, Rogov V, Hofmann K, Akira S, Dötsch V, Dikic I. Involvement of the ubiquitin-like domain of TBK1/IKK-i kinases in regulation of IFN-inducible genes. EMBO J 2007, 26:3451-62. |
|
| 3. | Raguz J, Wagner S, Dikic I, Hoeller D. Suppressor of T-cell receptor signalling 1 and 2 differentially regulate endocytosis and signalling of receptor tyrosine kinases. FEBS Lett. 2007, 581:4767-72. |
|
| 4. | Dikic I, Schmidt MH. Malfunctions within the Cbl interactome uncouple receptor tyrosine kinases from destructive transport. Eur J Cell Biol 2007, 86:505-12. |
|
| 5. | Sargin B, Choudhary C, Crosetto N, Schmidt MH, Grundler R, Rensinghoff M, Thiessen C, Tickenbrock L, Schwable J, Brandts C, August B, Koschmieder S, Bandi SR, Duyster J, Berdel WE, Muller-Tidow C, Dikic I, Serve H. Flt3-dependent transformation by inactivating c-Cbl mutations in AML. Blood 2007, 110:1004-12. |
|
| 6. | Kirkin V, Dikic I. Role of ubiquitin and UBl-binding proteins in cell signalling. Curr Opin Cell Biol 2007, 19:199-205. |
|
| 7. | Tossidou I, Kardinal C, Peters I, Kriz W, Shaw A, Dikic I, Tkachuk S, Dumler I, Haller H, Schiffer M. CD2AP/CIN85 balance determines RTK-signaling response in podocytes. J Biol Chem 2007, 282:7457-64. |
|
| 8. | Parker JL, Bielen AB, Dikic I, Ulrich HD. Contributions of ubiquitin- and PCNA-binding domains to the activity of polymerase in Saccharomyces cerevisiae. Nucleic Acids Res 2007, 35:881-9. |
|
| 2006 | ||
| 1. | Dikic I, Crosetto N, Calatroni S, Bernasconi P. Targeting ubiquitin in cancers. Eur J Cancer 2006, 42:3095-102. |
|
| 2. | Crosetto N, Bienko M, Dikic I. Ubiquitin hubs in oncogenic networks. Mol Cancer Res 2006, 4:899-904. |
|
| 3. | Schmidt MHH, Dikic I. Ubiquitin and NEDD8: Brothers in Arms. Science STKE 2006, 362:pe50. |
|
| 4. | Moncalian G, Cardenes N, Deribe YL, Spinola-Amilibia M, Dikic I, Bravo J. Atypical polyproline recognition by the CMS N-terminal SH3 domain. J Biol Chem 2006, 281:38845-53. |
|
| 5. | Guo C, Tang TS, Bienko M, Parker JL, Bielen AB, Sonoda E, Takeda S, Ulrich HD, Dikic I, Friedberg EC. Ubiquitin-Binding Motifs in REV1 Protein Are Required For Its Role in the Tolerance of DNA Damage. Mol Cell Biol 2006, 26:8892-900. |
|
| 6. | Hoeller D, Hecker C, Dikic I. Ubiquitin and ubiquitin-ilke proteins in cancer pathogenesis. Nat Rev Cancer 2006, 6:776-88. |
|
| 7. | Seet BT, Dikic I, Zhou MM, Pawson T. Reading protein modifications with interaction domains. Nat Rev Mol Cell Biol 2006, 7:473-483. |
|
| 8. | Ikeda F and Dikic I. CYLD in ubiquitin signalling and tumor pathogenesis, Cell 2006, 125:643-645. |
|
| 9. | Hoeller D, Crosetto N, Blagoev B, Raiborg C, Tikkanen R, Wagner S, Kowanetz K, Breitling R, Mann M, Stenmark H, Dikic I. Regulation of ubiquitin-binding proteins by monoubiquitylation. Nat Cell Biol 2006, 8:163-9. |
|
| 10. | Hecker CM, Rabiller M, Haglund K, Bayer P, Dikic I. Specification of SUMO 1 and SUMO2 interacting motifs. J Biol Chem 2006, 281:1611-27. |
|
| 11. | Husnjak K, Dikic I. EGFR trafficking: parkin' in a jam. Nat Cell Biol 2006, 8:787-8. |
|
| 12. | Schmidt MH, Husnjak K, Szymkiewicz I, Haglund K, Dikic I. Cbl escapes Cdc42-mediated inhibition by downregulation of the adaptor molecule betaPix. Oncogene 2006, 25:3071-8. |
|
| 13. | Schmidt MHH, Dikic I. Methods to monitor EGF receptor degradation. Methods Mol Biol 2006, 327:131-8. | |
| 14. | Katic M, Bosnjak B, Gall-Troselj K, Dikic I, Pavelic K. A clinoptilolite effect on cell media and the consequent effects on tumor cells in vitro. Front Biosci 2006, 11:1722-32. | |
| 2005 | ||
| 1. | Bienko M, Green CM, Crosetto N, Rudolf F, Zapart G, Coull B, Kannouche P, Wieder G, Peter M, Lehmann AR, Hofmann K, Dikic I. Novel ubiquitin-binding domains in Y-family polymerases regulate translesion DNA synthesis. Science 2005, 310:1821-4. | |
| 2. | Jozic D, Cárdenes N, Lissanu Deribe Y, Moncalián G, Hoeller D, Groemping Y, Dikic I., Rittinger K., Bravo J. Cbl promotes clustering of endocytic adaptor proteins. Nat Struct Mol Biol 2005, 12:972 - 9. | |
| 3. | Haglund K, Dikic I. Ubiquitylation and cell signalling. EMBO J 2005, 24:3353-9. | |
| 4. | Schmidt MHH, Dikic I. Cbl interactome and its functions. Nat Rev Cell Mol Biol 2005, 6:907-19. | |
| 5. | Molfetta R, Belleudi F, Peruzzi G, Morrone S, Leone L, Dikic I, Piccoli M, Frati L, Torrisi MR, Santoni A, Paolini R. CIN85 regulates the ligand-dependent endocytosis of the IgE receptor: a new molecular mechanism to dampen mast cell function. J Immunol 2005, 175: 4208-16. | |
| 6. | Aissouni Y, Zapart G, Iovanna JL, Dikic I, Soubeyran P. CIN85 regulates the ability of MEKK4 to activate the p38 MAP kinase pathway. Biochem Biophys Res Commun 2005, 338:808-14. | |
| 7. | Haglund K, Schmidt MHH, Wong ESM, Guy GR, Dikic I. Sprouty2 acts at the Cbl/CIN85 interface to inhibit EGFR downregulation. EMBO reports 2005, 6:635-41. | |
| 8. | Crosetto N, Tikkanen R, Dikic I. Oncogenic breakdowns in endocytic adaptor proteins. FEBS Lett 2005, 579:3231-8. | |
| 9. | Sulic S, Panic L, Dikic I, Volarevic S. Deregulation of cell growth and malignant transformation. Croat Med J 2005 46:622-38. | |
| 10. | Banno Y, Ohguchi K, Matsumoto N, Koda M, Ueda M, Hara A, Dikic I, Nozawa Y. Implication of phospholipase D2 in oxidant-induced phosphoinositide 3-kinase signaling via Pyk2 activation in PC12 cells. J Biol Chem 2005, 280:16319-24. | |
| 11. | Hoeller D, Volarevic S, Dikic I. Compartmentalization of growth factor receptor signalling. Curr Opin Cell Biol 2005, 17:107-11. | |
| 12. | Shimokawa N, Dikic I, Sugama S, Koibuchi N. Molecular responses to acidosis of central chemosensitive neurons in brain. Cellular Signaling 2005, 17:799-808. | |
| 13. | Schmidt MHH, Dikic I, Bogler O: Src phosphorylation of Alix/AIP1 modulates its interaction with binding partners and antagonizes its activities. J Biol Chem 2005, 280:3414-25. | |
| 2004 | ||
| 1. | Schmidt MHH, Hoeller D, Furnari FB, Cavenee WK, Dikic I, Bögler O. Alix/AIP1 interacts constitutively with EGFR and antagonizes its downregulation by the Cbl-SETA/CIN85 complex. Mol Cell Biol 2004, 24:8981-93. | |
| 2. | Szymkiewicz I, Shupliakov O, Dikic I. Cargo-selective and compartment-specific endocytic scaffold proteins. Biochem J 2004, 383:1-11. | |
| 3. | Kowanetz K, Crosetto N, Haglund K, Schmidt MHH, Heldin C-H, Dikic I Suppressors of T-cell receptor signaling Sts1 and Sts2 bind to Cbl and inhibit endocytosis of receptor tyrosine kinases. J Biol Chem 2004, 279:32786-95. | |
| 4. | Kowanetz K, Dikic I. Trafficking inside the cell - from a molecular point of view. Futura 2004, 19:81-7. | |
| 5. | Haglund K, Ivankovic-Dikic I, Shimokawa N, Kruh G, Dikic I. Recruitment of Pyk2 and Cbl to lipid rafts mediates signals important for actin reorganization in growing neurites. J Cell Sci 2004, 117:2557-68. | |
| 6. | Kowanetz K, Husnjak K, Höller D, Kowanetz M, Soubeyran P, Hirsch D, Schmidt MHH, Pavelic K, De Camilli P, Randazzo PA, Dikic I. CIN85 associates with multiple effectors controlling intracellular trafficking of EGF receptors. Mol Biol Cell 2004, 15, 3155-66. | |
| 7. | Dikic I. ALIX-ing phospholipids with endosome biogenesis. BioEssays 2004, 26:604-7. | |
| 8. | Szymkiewicz I, Destaing O, Jurdic P, Dikic I. SH3P2 in complex with Cbl and Src. FEBS Letters 2004, 565:33-8. | |
| 9. | Höller D, Dikic I. Receptor endocytosis via ubiquitin dependent and independent pathways. Biochem Pharmacol 2004, 67:1013-7. | |
| 10. | Shimokawa N, Qiu CH, Seki T, Dikic I, Koibuchi N. Phosphorylation of JNK is involved in regulation of H+-induced c-Jun expression. Cell Signal 2004, 16:723-29. | |
| 2003 | ||
| 1. | Dikic I. Mechanisms controlling EGF receptor endocytosis and degradation. Biochem Soc Trans 2003, 31:1178-81. | |
| 2. | Haglund K, DiFiore PP, Dikic I. Distinct monoubiquitin signals in receptor endocytosis. Trends Bioch Sci 2003, 28:598-604. | |
| 3. | Kowanetz K, Terzic J, Dikic I. Dab2 links CIN85 with clathrin-mediated receptor internalization. FEBS Letters 2003, 554:81-7. | |
| 4. | Haglund S, Sigismund S, Polo S, Szymkiewicz I, Di Fiore PP, Dikic I. Multiple monoubiquitination of receptor tyrosine kinases is sufficient for their endocytosis and degradation, Nature Cell Biol 2003, 5:461-66. | |
| 5. | Dikic I, Szymkiewicz I, Soubeyran P. Cbl signaling networks in the regulation of cell function. Cell Mol Life Sci 2003, 60:1805-27. | |
| 6. | Dikic I, Giordano S. Negative receptor signalling. Curr Opin Cell Biol 2003, 15:128-35. | |
| 7. | Kowanetz K, Szymkiewicz I, Haglund K, Kowanetz M, Husnjak K, Taylor JD, Soubeyran P, Engstrom U, Ladbury JE, Dikic I. Identification of a novel proline-arginine motif involved in CIN85-dependent clustering of Cbl and downregulation of EGF receptors. J Biol Chem 2003, 278:39735-46. | |
| 8. | Soubeyran P, Barac A, Szymkiewicz I, Dikic I. Cbl/ArgBP2 complex mediates ubiquitination and degradation of c-Abl. Biochem J 2003, 370:29-34. | |
| 9. | Piiper A, Lutz MP, Cramer H, Elez R, Kronenberger B, Dikic I, Muller-Esterl W, Zeuzem S. Protein kinase A mediates cAMP-induced tyrosine phosphorylation of the epidermal growth factor receptor. Biochem Biophys Res Commun 2003, 30:848-54. | |
| 2002 | ||
| 1. | Haglund K, Shimokawa N, Szymkiewicz I, Dikic I. Cbl-directed monoubiquitination of CIN85 is involved in regulation of ligand-induced degradation of EGF receptors. PNAS USA 2002, 99:12191-6. | |
| 2. | Soubeyran P, Kowanetz K, Szymkiewicz I, Langdon W, Dikic I. Cbl/CIN85/endophilin complex mediates ligand-induced downregulation of EGF receptors. Nature 2002, 416:183-7. Accompanied by the New and Views article ”Molecular ticket to enter cells” Nature 2002, 416:133-5. | |
| 3. | Szymkiewicz I, Kowanetz K, Dinarina A, Soubeyran P, U. Engstrom, Lipkowitz S, Dikic I. CIN85 participates in Cbl-b-mediated downregulation of receptor tyrosine kinases. J Biol Chem 2002, 277:39666-72. | |
| 4. | Dikic I. CIN85/CMS family of adaptor molecules. FEBS Letters 2002, 592:110-5. | |
| 5. | Dikic I, Haglund K, Ivankovic-Dikic I. Regulation of cell morphology by a proline-rich tyrosine kinase Pyk2. Period Biol 2002, 104:11-8. | |
| 6. | Piiper A, Dikic I, Lutz MP, Leser J, Kronenberger B, Elez R, Cramer H, Müller-Esterl W, Zeuzem S. Cyclic AMP induces transactivation of the receptors for epidermal growth factor and nerve growth factor thereby modulating activation of MAP kinase, Akt and neurite outgrowth in PC12 cells. J Biol Chem 2002, 277:43623-30. | |
| 7. | Shimokawa N, Okada J, Haglund K, Dikic I, Koibuchi N, Miura M. Past-A. A novel proton associated sugar transporter, regulates glucose homeostasis in the brain. J of Neurosci 2002, 22(21):9160-5. | |
| 8. | Sajan MP, Bandyopadhyay G, Kanoh Y, Standaert ML, Quon MJ, Reed BC, Dikic I, Farese RV. Sorbitol Activates Atypical Protein Kinase Cs and GLUT 4 Glucose Transporter Translocation/Glucose Transport Through Proline-Rich Tyrosine Kinase-2, the Extracellular Signal-Regulated Kinase Pathway and Phospholipase D, Biochem J 2002, 362:665-74. | |
| 9. | Picascia A, Stanzione R, Chieffi P, Kisslinger A, Dikic I, Tramontano D. Proline-rich tyrosine kinase 2 regulates proliferation and differentiation of prostate cells. Mol Cell Endocrinol 2002, 186:81-7. | |
| 2001 | ||
| 1. | Blaukat A, Pizard A, Breit A, Wernstedt C, Alhenc-Gelas F, Müller-Esterl W, Dikic I. Determination of bradykinin B2 receptor in vivo phosphorylation sites and their role in receptor function. J Biol Chem 2001, 276:40431-40. | |
| 2. | Soubeyran P, Haglund K, Garcia S, Barth B-U, Iovanna J, Dikic I. Homeobox gene Cdx-1 regulates Ras, Rho and PI3 kinase pathways leading to transformation and tumorigenesis of intestinal epithelial cells. Oncogene 2001, 20:4180-7. | |
| 3. | Blaukat A, Dikic I. Activation of sphingosine kinase by the bradykinin B2 receptor and its implication in regulation of the ERK/MAPK pathway. Biol Chem 2001, 382:135-9. | |
| 4. | Pizard A, Blaukat B, Michineau S, Dikic I, Müller-Esterl W, Alhenc-Gelas F, Rajerison RM. Palmitoylation of the human bradykinin B2 receptor influences ligand efficacy. Biochemistry 2001, 40:15743-51. | |
| 5. | Bandyopadhyay G, Sajan MP, Kanoh Y, Standaert ML, Quon MJ, Reed BC, Dikic I, Farese RV. Glucose Activates Protein Kinase C-z/l Through Proline-Rich Tyrosine Kinase-2, Extracellular Signal-Regulated Kinase and Phospholipase D. A Novel Mechanism for Activating Glucose Transporter Translocation. J Biol Chem 2001, 276:35537-45. | |
| 6. | Pavelic K, Hadzija M, Bedrica Lj, Pavelic J, Dikic I, Katic M, Kralj M, Herak Bosnar M, Kapitanovic S, Poljak-Blazi M, Krizanac S, Stojkovic R, Juri M, Subotic B, Colic M. Mechanically treated natural clinoptilolite zeolite - new adjuvant agent in anticancer therapy. J Mol Med 2001, 78:708-20. | |
| 2000 | ||
| 1. | Ivankovic-Dikic I, Grönroos E, Blaukat A, Barth B-U, Dikic I. Pyk2 and FAK regulate neurite outgrowth induced by growth factors and integrins. Nat Cell Biol 2000, 2:574-81. | |
| 2. | Blaukat A, Barac A, Cross MJ, Offermanns S, Dikic I. G protein-coupled receptor-mediated MAP kinase activation through cooperation of Gq and Gi signals. Mol Cell Biol 2000, 20:6837-48. | |
| 3. | Bandyopadhyay G, Sajan MP, Kanoh Y, Standaert ML, Burke RT, Jr., Quon M, Reed BC, Dikic I, Noel LE, Newgard CB, Farese RV. Glucose activates MAP kinase (ERK) through Pyk2 and the Glut1 glucose transporter. J Biol Chem 2000, 275:40817-26. | |
| 4. | Sasaki A, Yasukawa H, Kinjyo I, Shouda T, Minoguchi S, Kitamura T, Dikic I, Yoshimura A. CIS3/SOCS3 suppresses EPO signaling through binding to JAK2 and the receptor phosphotyrosine, Y401. J Biol Chem 2000, 275:29338-47. | |
| 1999 | ||
| 1. | Dikic I, Blaukat A. Protein tyrosine kinase-mediated pathways in G protein-coupled receptor signaling. Cell Biochem Biophys 1999, 30:369-87. | |
| 2. | Dikic I, Pavelic K. International Conference on Signal Transduction is recognized for scientific quality and education of young scientists. Period Biol. 1999, 101:3-5. | |
| 3. | Dikic I, Seitz HJ. Dubrovnik conferences, B.I.F. Futura 1999, 14:36-40. | |
| 4. | Soubeyran P, André F, Lissitzky JC, Mallo GV, Moucadel V, Roccabianca M, Rechreche H, Marvaldi J, Dikic I, Dagorn JC, Iovanna J. Cdx1 promotes differentiation in a model intestinal epithelial cell. Gastroenterology 1999, 117:1326-38. | |
| 5. | Blaukat A, Ivankovic-Dikic I, Gronroos E, Dolfi F, Tokiwa G, Vuori K, Dikic I. Adaptor proteins Grb2 and Crk couple Pyk2 with activation of specific MAP kinase cascades. J Biol Chem 1999, 274:14893-901. | |
| 6. | Blaukat A, Pizard A, Rajerison RM, Gelas FA, Muller-Esterl W, Dikic I. Activation of MAP kinase by the bradykinin B2 receptor is independent of receptor phosphorylation and phosphorylation-triggered internalisation. FEBS Letters 1999, 3:337-41. | |
| 7. | Yamashita H, Avraham S, Jiang S, Dikic I, Avraham H. The csk homologous kinase associates with TrkA receptors and is involved in neurite outgrowth of PC12 cells. J Biol Chem 1999, 274:15059-65. | |
| 1998 | ||
| 1. | Dikic I, Dikic I, Schlessinger J. Identification of a new Pyk2 isoform implicated in chemokine and antigen receptor signaling. J Biol Chem 1998, 273:14301-08. | |
| 2. | Miyazaki T, Takaoka A, Nogueira L, Dikic I, Fujii H, Tsujino S, Mitani Y, Maeda M, Schlessinger J, Taniguchi T. Pyk2 is a downstream mediator of the IL-2 receptor-coupled Jak signaling pathway. Genes Dev 1998 Mar 15, 12:770-5. | |
| 1997 | ||
| 1. | Davis CB*, Dikic I*, Unutmaz D, Hill CM, Arthos J, Siani M, Thompson DA, Schlessinger J, Littman DR. Signal transduction due to HIV-1 envelope interactions with chemokine receptors CXCR4 or CCR5. J Exp Med 1997, 186:1793-8. * equally contributed authors. | |
| 2. | Oian D, Lev S, van Oers NS, Dikic I, Schlessinger J, Weiss A. Tyrosine phosphorylation of Pyk2 is selectively regulated by Fyn during TCR signaling. J Exp Med 1997, 185(7):1253-9. | |
| 1996 | ||
| 1. | Dikic I, Tokiwa G, Lev S, Courtneidge SA, Schlessinger J. A role for Pyk2 and Src in linking G-protein-coupled receptors with MAP kinase activation. Nature 1996, 383:547-50. | |
| 2. | Tokiwa G*, Dikic I*, Lev S, Schlessinger J. Activation of Pyk2 by stress signals and coupling with JNK signaling pathway. Science 1996, 273:792-4. * equally contributed authors. | |
| 3. | Mohammadi M*, Dikic I*, Sorokin A, Burgess WH, Jaye M, Schlessinger J. Identification of six novel autophosphorylation sites on fibroblast growth factor receptor 1 and elucidation of their importance in receptor activation and signal transduction. Mol Cell Biol 1996, 16:977-89. * equally contributed authors. | |
| 4. | Dikic I. Regulation of HIV-1 infection by chemokine receptors. Acta Med Croat 1996, 50:163-8. | |
| 1995 | ||
| 1. | Dikic I. Central role of the Ras signaling pathway in neuronal differentiation of PC12 cells. Croat Med J 1995, 36:7-15. | |
| 2. | Dikic I, Batzer AG, Blaikie P et al. Shc binding to nerve growth factor receptor is mediated by the phosphotyrosine interaction domain. J Biol Chem 1995, 270:15125-9. | |
| 3. | Galisteo ML, Dikic I, Batzer A, Langdon W, Schlessinger J. Tyrosine phosphorylation of the c-cbl proto-oncogene protein product and association with epidermal growth factor (EGF) receptor upon EGF stimulation. J Biol Chem 1995, 270:20242-5. | |
| 1994 | ||
| 1. | Dikic I, Schlessinger J, Lax I. PC12 cells overexpressing the insulin receptor undergo insulin-dependent neuronal differentiation. Curr Biol 1994, 4:702-8. | |
| 2. | Spivak-Kroizmann T, Lemmon MA, Dikic I, Ladbury JE, Pinchasi D, Jaye M, Crumley G, Schlessinger J, Lax I. Heparin-induced oligomerization of FGF molecules is responsible for FGF-receptor dimerization and activation. Cell 1994, 79:1015-24. | |
| 1992 | ||
| 1. | Marusic A, Dikic I, Vukicevic S, Marusic M. New bone formation induced by demineralized bone matrix in immunosupressed rats. Experientia 1992, 148: 783-5. | |
| 1990 | ||
| 1. | Marusic A, Dikic I, Marusic M. Cellular and morphological changes in lymphoid organs after a single injection of interleukin 1 in the mouse. Agents Action 1990, 31:280-4. | |